All filters
Abstracts
Current approaches for identifying and managing HIV treatment failure among children, adolescents, and young people in sub-Saharan Africa: Multi-country experience from the New Horizons Collaborative
N. Rakhmanina
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Traditional healers can increase uptake of HIV testing among adults of unknown serostatus: results from a cluster randomized pilot study in southwestern Uganda
R. Sundararajan
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Positive Effects of Intensified Preventive Calls/Home Visits on Early Retention Among Adults Newly Initiated on Antiretroviral Therapy in Zambézia Province, Mozambique
C. De Schacht
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
DTG+3TC vs DTG+TDF/FTC (GEMINI-1&-2): Confirmed Virologic Withdrawals Through Week 96
J. van Wyk
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Does Dolutegravir causes weight gain: a retrospective observational cohort study from Lusaka, Zambia
D. Mwamba
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Dolutegravir- versus low-dose Efavirenz-based regimen for the initial treatment of HIV-1 infection in Cameroon: 96-week results of the ANRS 12313 – NAMSAL trial
C. Kouanfack
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Doing Index Testing differently: A health education approach for old clients returning for refill and those newly initiating ART to effectively participate in index testing.
P. Nji Atanga
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Effectiveness of male Strategy (MS) in HIV case identification and linkage of MLHIV to treatment in Cameroon.
E. Njemkerk
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
A Hybrid Interpersonal Training Model to build Capacity for Health-Care-Providers (HITCH) to Manage Children, Adolescents and Adults on Third-Line Anti-Retro Viral (ART) Therapy in Uganda.
E. Magongo
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Switching to DTG/3TC Fixed-Dose Combination (FDC) Is Non-inferior to Continuing a TAF-Based Regimen Through 48 Weeks: Subgroup Analyses From the TANGO Study
J. van Wyk
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Optimizing HIV Treatment among Children in Mozambique
M. Tomo De Deus
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Impact of community resource persons and mobile phone technology on return to HIV care among loss to follow up HIV clients in 104 HIV facilities in Uganda
A. Mugisa
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
U=U - Catalyst or Barrier for Men's Engagement in ART? Stakeholder Views from Blantyre, Malawi
A. Berner-Rodoreda
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Patient-reported reasons for missed appointments among ART patients in South Africa
C. Biedron
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Evaluation of Second Line Antiretroviral Programmatic and Treatment Outcomes in Mozambique between 2015-2017
A. Muteerwa
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
"You are not benefiting us by keeping us away": Why do some eligible people on antiretroviral therapy (ART) decline to participate in Ethiopia's appointment spacing model with 6-month ART dispensing?
J. Mantell
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Minimal cross-resistance to tenofovir in children and adolescents failing abacavir-based ART makes them eligible for tenofovir-lamivudine-dolutegravir treatment.
K. Steegen
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Factors associated with unsuppressed viral load among patients enrolled in the Community HIV Care Program in Botswana. A retrospective cross-sectional study.
C. Trapence
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Improving retention in ART care using Call-2Care© approach: A snapshot from Defence Forces of Zambia (DFZ)
P. Makelele
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
The effect of home-based care in achieving viral load coverage in two high volume facilities in Akwa Ibom state, Nigeria
O. Toyo
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Improving linkage to antiretroviral therapy using a peer attachment model in selected facilities in the Southern Highland Zone of Tanzania
A. Ngwalle
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Acceptability of Quadrimune, a new Abacavir/Lamivudine/Lopinavir/Ritonavir paediatric fixed dose combination
V. Musiime
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Limited increase in primary HIV‐1C drug resistance mutations in treatment naïve individuals in Ethiopia
K. Ghezehegn
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Comparative study on the liver profile of HIV positive pregnant women and HIV positive non-pregnant women attending the Bamenda Regional Hospital, Cameroon
M. Alice Enekegbe
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020